Kestra Medical Technologies (KMTS) Competitors $22.97 +0.39 (+1.73%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KMTS vs. GKOS, TMDX, NVST, SLNO, LIVN, WRBY, EYE, INSP, PRCT, and LMATShould you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), Soleno Therapeutics (SLNO), LivaNova (LIVN), Warby Parker (WRBY), National Vision (EYE), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Kestra Medical Technologies vs. Its Competitors Glaukos TransMedics Group Envista Soleno Therapeutics LivaNova Warby Parker National Vision Inspire Medical Systems PROCEPT BioRobotics LeMaitre Vascular Kestra Medical Technologies (NASDAQ:KMTS) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Do institutionals and insiders believe in KMTS or GKOS? 99.0% of Glaukos shares are owned by institutional investors. 3.6% of Kestra Medical Technologies shares are owned by company insiders. Comparatively, 6.4% of Glaukos shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger earnings and valuation, KMTS or GKOS? Kestra Medical Technologies has higher earnings, but lower revenue than Glaukos. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKestra Medical Technologies$59.81M19.76-$113.81MN/AN/AGlaukos$383.48M12.76-$146.37M-$1.65-51.69 Does the media refer more to KMTS or GKOS? In the previous week, Glaukos had 5 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 9 mentions for Glaukos and 4 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.55 beat Glaukos' score of -0.21 indicating that Kestra Medical Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Glaukos 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend KMTS or GKOS? Kestra Medical Technologies currently has a consensus target price of $27.33, indicating a potential upside of 19.00%. Glaukos has a consensus target price of $116.92, indicating a potential upside of 37.09%. Given Glaukos' stronger consensus rating and higher possible upside, analysts plainly believe Glaukos is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kestra Medical Technologies 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57Glaukos 2 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.69 Is KMTS or GKOS more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to Glaukos' net margin of -21.43%. Kestra Medical Technologies' return on equity of 0.00% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Kestra Medical TechnologiesN/A N/A N/A Glaukos -21.43%-8.59%-6.61% SummaryGlaukos beats Kestra Medical Technologies on 8 of the 14 factors compared between the two stocks. Get Kestra Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KMTS vs. The Competition Export to ExcelMetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.18B$10.36B$6.02B$10.45BDividend YieldN/A1.90%5.73%4.82%P/E RatioN/A20.9785.1227.24Price / Sales19.7630.83589.92133.47Price / CashN/A25.5625.7730.18Price / Book5.743.4412.676.76Net Income-$113.81M$210.63M$3.32B$276.59M7 Day Performance-5.82%-1.56%0.50%0.86%1 Month Performance5.22%0.55%9.42%8.17%1 Year PerformanceN/A-6.81%79.11%43.66% Kestra Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KMTSKestra Medical Technologies1.495 of 5 stars$22.97+1.7%$27.33+19.0%N/A$1.18B$59.81M0.00300GKOSGlaukos4.3269 of 5 stars$87.45+3.5%$122.00+39.5%-34.5%$5.02B$432.95M-53.00780Analyst ForecastTMDXTransMedics Group3.3633 of 5 stars$115.69-0.3%$125.40+8.4%-17.4%$3.94B$441.54M59.94210News CoveragePositive NewsAnalyst ForecastNVSTEnvista3.97 of 5 stars$20.84+1.3%$20.92+0.4%+6.1%$3.46B$2.51B65.1412,300SLNOSoleno Therapeutics4.3937 of 5 stars$59.21+2.1%$115.09+94.4%+17.4%$3.15BN/A-14.3030LIVNLivaNova2.216 of 5 stars$53.37+4.2%$59.71+11.9%-1.4%$2.91B$1.25B-13.722,900WRBYWarby Parker2.3444 of 5 stars$26.19-1.0%$24.06-8.1%+40.7%$2.75B$771.32M-374.023,780Positive NewsEYENational Vision2.1565 of 5 stars$28.87-1.3%$24.73-14.3%+162.6%$2.29B$1.82B-160.3913,411Positive NewsINSPInspire Medical Systems4.8259 of 5 stars$76.55+3.3%$154.43+101.7%-63.2%$2.26B$802.80M44.251,246PRCTPROCEPT BioRobotics3.0067 of 5 stars$35.97+3.4%$70.00+94.6%-54.0%$2.00B$274.95M-23.21430LMATLeMaitre Vascular3.74 of 5 stars$87.85+1.1%$97.60+11.1%-5.8%$1.99B$234.64M42.65490 Related Companies and Tools Related Companies GKOS Alternatives TMDX Alternatives NVST Alternatives SLNO Alternatives LIVN Alternatives WRBY Alternatives EYE Alternatives INSP Alternatives PRCT Alternatives LMAT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KMTS) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
